Cell-话题@MedSci

#Cell#

4201篇内容 | 8967人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1872013, encodeId=790118e20138c, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=Cell Death & Disease：miR-361-3p能够增加前列腺癌对恩杂鲁胺的敏感性, objectType=article, longId=202020, objectId=3c9120202076, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c9120202076, replyNumber=0, likeNumber=71, createdTime=2021-06-26, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c9120202076, moduleTitle=Cell Death & Disease：miR-361-3p能够增加前列腺癌对恩杂鲁胺的敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c9120202076)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1872067, encodeId=6fdb18e206719, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=Cell Res：黄波团队揭秘新冠患者早期沉默式乏氧的原因, objectType=article, longId=203614, objectId=8b12203614a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b12203614a4, replyNumber=0, likeNumber=80, createdTime=2020-12-24, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b12203614a4, moduleTitle=Cell Res：黄波团队揭秘新冠患者早期沉默式乏氧的原因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b12203614a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1872237, encodeId=59e518e22375d, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=Celltrion发布抗COVID-19单克隆抗体治疗瑞丹维单抗(CT-P59)全球III期试验的阳性顶线结果, objectType=article, longId=212850, objectId=8a1421285025, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a1421285025, replyNumber=0, likeNumber=74, createdTime=2021-09-11, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a1421285025, moduleTitle=Celltrion发布抗COVID-19单克隆抗体治疗瑞丹维单抗(CT-P59)全球III期试验的阳性顶线结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a1421285025)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1872063, encodeId=57bd18e206340, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=Cell Death & Disease：MiRNA-671-5p通过靶向NFIA/CRYAB途径促进前列腺癌的发展和转移, objectType=article, longId=203548, objectId=f9e12035488c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9e12035488c, replyNumber=0, likeNumber=77, createdTime=2021-09-08, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9e12035488c, moduleTitle=Cell Death & Disease：MiRNA-671-5p通过靶向NFIA/CRYAB途径促进前列腺癌的发展和转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9e12035488c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1872168, encodeId=5e1018e2168d6, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=Cell ：新冠病毒变异，疫苗效力明显下降！, objectType=article, longId=208405, objectId=bbd920840569, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbd920840569, replyNumber=0, likeNumber=53, createdTime=2021-03-16, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbd920840569, moduleTitle=Cell ：新冠病毒变异，疫苗效力明显下降！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbd920840569)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1872021, encodeId=7ff918e202169, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=Cell Death Dis：SPATS2调控细胞周期促进肝癌的发生发展, objectType=article, longId=202307, objectId=195120230ef9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=195120230ef9, replyNumber=0, likeNumber=85, createdTime=2021-02-04, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=195120230ef9, moduleTitle=Cell Death Dis：SPATS2调控细胞周期促进肝癌的发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=195120230ef9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1872253, encodeId=f55018e2253de, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=Cell：「小身体，大智慧」Cell 重磅揭示大肠杆菌染色体折叠模式及影响因素, objectType=article, longId=214241, objectId=728121424103, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=728121424103, replyNumber=0, likeNumber=71, createdTime=2021-08-23, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=728121424103, moduleTitle=Cell：「小身体，大智慧」Cell 重磅揭示大肠杆菌染色体折叠模式及影响因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=728121424103)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1872061, encodeId=3f1e18e2061b1, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=Cell Metabolism: 重大进展！山东大学易凡团队鉴定了糖尿病性肾脏疾病的潜在治疗新靶点, objectType=article, longId=203456, objectId=2c04203456d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c04203456d5, replyNumber=0, likeNumber=86, createdTime=2021-01-04, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c04203456d5, moduleTitle=Cell Metabolism: 重大进展！山东大学易凡团队鉴定了糖尿病性肾脏疾病的潜在治疗新靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c04203456d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1872155, encodeId=385318e215596, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=Cancer Cell：一物降一物！新研究揭示绕过突变抑癌基因，根除癌细胞新机制, objectType=article, longId=207451, objectId=372a20e451ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=372a20e451ef, replyNumber=0, likeNumber=65, createdTime=2021-08-23, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=372a20e451ef, moduleTitle=Cancer Cell：一物降一物！新研究揭示绕过突变抑癌基因，根除癌细胞新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=372a20e451ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1872065, encodeId=acb818e2065af, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=Cancer Cell :突破！李林/吴殿青/李昊合作发现治疗室管膜瘤的新策略, objectType=article, longId=203591, objectId=d27320359188, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d27320359188, replyNumber=0, likeNumber=94, createdTime=2021-10-30, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d27320359188, moduleTitle=Cancer Cell :突破！李林/吴殿青/李昊合作发现治疗室管膜瘤的新策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d27320359188)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1872111, encodeId=249318e2111f5, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=Cell: 连续取得进展！施一公团队首次揭开阿尔兹海默重要蛋白γ分泌酶与药物结合全过程, objectType=article, longId=205013, objectId=36b020501375, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36b020501375, replyNumber=0, likeNumber=71, createdTime=2021-03-31, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36b020501375, moduleTitle=Cell: 连续取得进展！施一公团队首次揭开阿尔兹海默重要蛋白γ分泌酶与药物结合全过程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36b020501375)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1871999, encodeId=62eb18e1999a2, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=J Cell Physiol：PDLSCs的外泌体microRNA-155-5p通过靶向sirtuin-1调节慢性牙周炎的Th17/Treg平衡, objectType=article, longId=201562, objectId=4f9a20156223, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f9a20156223, replyNumber=0, likeNumber=84, createdTime=2020-10-06, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f9a20156223, moduleTitle=J Cell Physiol：PDLSCs的外泌体microRNA-155-5p通过靶向sirtuin-1调节慢性牙周炎的Th17/Treg平衡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f9a20156223)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1872243, encodeId=f89718e2243d2, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=Cancer Cell：94% 的癌症患者对 COVID-19 疫苗反应良好, objectType=article, longId=213666, objectId=98df21366607, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98df21366607, replyNumber=0, likeNumber=81, createdTime=2021-09-10, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98df21366607, moduleTitle=Cancer Cell：94% 的癌症患者对 COVID-19 疫苗反应良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98df21366607)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1871986, encodeId=30a718e198641, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=AGING CELL：川大团队发现，长寿基因Klotho可改善阿尔茨海默病中Aβ的清除和认知, objectType=article, longId=201041, objectId=a97a2010416f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a97a2010416f, replyNumber=0, likeNumber=67, createdTime=2021-06-19, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a97a2010416f, moduleTitle=AGING CELL：川大团队发现，长寿基因Klotho可改善阿尔茨海默病中Aβ的清除和认知, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a97a2010416f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1872170, encodeId=455d18e21706f, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=Stem Cell Research & Therapy：干细胞与新冠肺炎：人类羊膜细胞是治疗SARS-CoV-2病毒的新希望吗？, objectType=article, longId=208519, objectId=42362085191f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42362085191f, replyNumber=0, likeNumber=113, createdTime=2021-05-24, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42362085191f, moduleTitle=Stem Cell Research & Therapy：干细胞与新冠肺炎：人类羊膜细胞是治疗SARS-CoV-2病毒的新希望吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42362085191f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1872078, encodeId=146a18e2078d0, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=Cell Death Differ：坏死性凋亡并非炎症性或散发性结肠癌的发生发展所必需的, objectType=article, longId=203857, objectId=921320385ea9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=921320385ea9, replyNumber=0, likeNumber=67, createdTime=2021-05-27, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=921320385ea9, moduleTitle=Cell Death Differ：坏死性凋亡并非炎症性或散发性结肠癌的发生发展所必需的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=921320385ea9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1871997, encodeId=3aca18e1997f6, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=J Cell Physiol：组蛋白脱甲基酶KDM7A是乳腺癌干细胞维持和细胞凋亡抑制所必需的, objectType=article, longId=201554, objectId=25b9201554e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25b9201554e0, replyNumber=0, likeNumber=67, createdTime=2021-07-09, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25b9201554e0, moduleTitle=J Cell Physiol：组蛋白脱甲基酶KDM7A是乳腺癌干细胞维持和细胞凋亡抑制所必需的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25b9201554e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1872151, encodeId=b2ef18e215112, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=Cell Death Differ：KDM4C通过表观遗传学修饰促进肺癌放疗抗性的产生, objectType=article, longId=207030, objectId=06a520e03048, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06a520e03048, replyNumber=0, likeNumber=90, createdTime=2021-05-09, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06a520e03048, moduleTitle=Cell Death Differ：KDM4C通过表观遗传学修饰促进肺癌放疗抗性的产生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06a520e03048)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1872015, encodeId=500c18e2015ee, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=Cell Death Differ：HDAC3异常表达抑制Klotho的转录促进肾纤维化的发生发展, objectType=article, longId=202097, objectId=534c20209e94, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=534c20209e94, replyNumber=0, likeNumber=95, createdTime=2021-03-02, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=534c20209e94, moduleTitle=Cell Death Differ：HDAC3异常表达抑制Klotho的转录促进肾纤维化的发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=534c20209e94)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1872127, encodeId=e06c18e2127d9, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, objectTitle=Cell Metabolism :突破！武汉大学李红良等团队首次解决了全球糖皮质激素治疗新冠用药难题，有望降低新冠患者死亡率, objectType=article, longId=205490, objectId=1f4b205490bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f4b205490bc, replyNumber=0, likeNumber=88, createdTime=2021-07-22, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f4b205490bc, moduleTitle=Cell Metabolism :突破！武汉大学李红良等团队首次解决了全球糖皮质激素治疗新冠用药难题，有望降低新冠患者死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f4b205490bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Cell

2020-05-29

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

Cell Death & Disease：miR-361-3p能够增加前列腺癌对恩杂鲁胺的敏感性

2021-06-26

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

Cell Res：黄波团队揭秘新冠患者早期沉默式乏氧的原因

2020-12-24

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

Celltrion发布抗COVID-19单克隆抗体治疗瑞丹维单抗(CT-P59)全球III期试验的阳性顶线结果

2021-09-11

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

Cell Death & Disease：MiRNA-671-5p通过靶向NFIA/CRYAB途径促进前列腺癌的发展和转移

2021-09-08

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

Cell ：新冠病毒变异，疫苗效力明显下降！

2021-03-16

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

Cell Death Dis：SPATS2调控细胞周期促进肝癌的发生发展

2021-02-04

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

Cell：「小身体，大智慧」Cell 重磅揭示大肠杆菌染色体折叠模式及影响因素

2021-08-23

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

Cell Metabolism: 重大进展！山东大学易凡团队鉴定了糖尿病性肾脏疾病的潜在治疗新靶点

2021-01-04

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

Cancer Cell：一物降一物！新研究揭示绕过突变抑癌基因，根除癌细胞新机制

2021-08-23

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

Cancer Cell :突破！李林/吴殿青/李昊合作发现治疗室管膜瘤的新策略

2021-10-30

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

Cell: 连续取得进展！施一公团队首次揭开阿尔兹海默重要蛋白γ分泌酶与药物结合全过程

2021-03-31

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

J Cell Physiol：PDLSCs的外泌体microRNA-155-5p通过靶向sirtuin-1调节慢性牙周炎的Th17/Treg平衡

2020-10-06

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

Cancer Cell：94% 的癌症患者对 COVID-19 疫苗反应良好

2021-09-10

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

AGING CELL：川大团队发现，长寿基因Klotho可改善阿尔茨海默病中Aβ的清除和认知

2021-06-19

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

Stem Cell Research & Therapy：干细胞与新冠肺炎：人类羊膜细胞是治疗SARS-CoV-2病毒的新希望吗？

2021-05-24

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

Cell Death Differ：坏死性凋亡并非炎症性或散发性结肠癌的发生发展所必需的

2021-05-27

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

J Cell Physiol：组蛋白脱甲基酶KDM7A是乳腺癌干细胞维持和细胞凋亡抑制所必需的

2021-07-09

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

Cell Death Differ：KDM4C通过表观遗传学修饰促进肺癌放疗抗性的产生

2021-05-09

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

Cell Death Differ：HDAC3异常表达抑制Klotho的转录促进肾纤维化的发生发展

2021-03-02

zhaozhouchifen (审核中...)

前往app查看评论内容

#Cell#

Cell Metabolism :突破！武汉大学李红良等团队首次解决了全球糖皮质激素治疗新冠用药难题，有望降低新冠患者死亡率

2021-07-22

科室
- - 订阅+
  - 更多科室
工具
服务